Abstract Reaction of o-aminophenylbenzimidazole with p-dimethylaminobenzaldehyde yielded 6-p-dimethylaminophenyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline, which was characterized by elemental analysis, IR, UV-Vis, 1 H NMR, 13 C NMR, mass spectral studies and X-ray crystal structure analysis. Studies on the antimicrobial activity of the compound revealed that it is active against fungus Yeast but not Bacillus subtilis. The compound crystallized in the space group P2 1 /n with the unit cell parameters a = 10.652(2) Å , b = 11.002(2) Å , c = 15.753(2) Å , b = 109.29(2)°and the structure was refined to an R-factor of 0.0479. The hydropyrimidine ring in the quinazoline moiety is in skew-boat conformation. The dimethylamino group attached to phenyl ring is in conjugation with it. The structure was stabilized by intermolecular C-H-N interactions. A few of the related quinazolines (6-p-hydroxyphenyl-5,6-dihydrobenzoimidazo [1,2-c]quinazoline; 6-phenyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline; 6-pyridyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline; 6-furyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline) were also examined for their biological activity, in addition to their characterization by IR, UV-Vis, 1 H and 13 C NMR spectral studies along with structural comparison.
Introduction
Quinazolines and their derivatives are of significant focus in the field of medicinal chemistry owing to their broad spectrum of biological properties. They are potent cytotoxic agents [1] [2] [3] [4] . Substituted quinazolines exhibit fungicidal, antimicrobial, CNS stimulant, diuretic, anti-inflammatory, anticancer, anti-hypertensive, anti-analgesic, antitumour and anti-HIV properties [5] [6] [7] . Some of the derivatives of indole [1,2-c] quinazoline show cataleptogenic activity [8] . Imidazole and their derivatives are widely used as ligating groups to transition metal ions [9, 10] . Multidentate N-heterocycles on coordination to metal ions produce organized supramolecules and they appear quite promising for the design of stable light conversion devices [11] . The application of imidazoles in medicinal chemistry [12] and chemistry of natural products/alkaloids [13, 14] are also well known. Heterocycles containing the imidazole moiety are of biological significance and display antibacterial, antifungal activities [15] , leukotriene B 4 receptor antagonist properties [16] , and potassium channel openers [17] . Benzimidazole and their derivatives as well as their metal complexes exhibit antibacterial, antifungal, veterinary, anthelmintic, insecticidal and virucidal activities [18, 19] . It is likely that the introduction of benzimidazole group into the quinazoline system would appreciably influence the biological activity of the latter. Benzimidazoquinazolines have been reported to exhibit virucidal properties and antifungal effects against dermatophytes [20] . Benzimidazo[1,2-c]quinazolines with 6-alkyl substitution have been evaluated for their bronchodilator activity [21] .
Presumably, the biological activity of 6-phenyl-5,6-dihydrobenzimidazo [1,2-c] quinazoline is related to its structure and electron donor/acceptor substituents. For instance, the introduction of electron-withdrawing substituents such as Cl, Br, F and NO 2 on the 6-phenyl ring rendered compounds devoid of antifungal activity [22] . On the contrary, an electron donor substituent such as OCH 3 group enhanced the activity of the compound by nearly five times as in T. mentagrophytes, E. floccosum and T. rubrum.
A detailed analysis of the structure of a compound would provide an opportunity to understand the biological function and its implication in the structural ramifications needed for binding to the receptors. In the present study, we have made an attempt to understand the influence of the substituent groups on the conformation of the dihydrobenzoimidazo[1,2-c]quinazoline ring system. With this in view, herein we report the synthesis, characterization, crystal structure and biological activity of 6-p-dimethylaminophenyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline.
Experimental

Apparatus
The electronic spectra of the N-heterocycles (I-V) were recorded in DMF using Shimadzu UV3101 PC. The IR spectra of the compounds were recorded as Nujol mulls using Shimadzu FTIR 8400S spectrometer.
1 H and 13 C NMR spectra of the N-heterocycles were recorded on Bruker av 400 MHz instrument using DMSO-d 6 as solvent. The 1 H and 13 C NMR chemical shifts are reported as d in parts per million relative to tetramethylsilane as an internal reference and coupling constants (J) are in Hz. The mass spectrum of I was recorded on Shimadzu GCMS QP5050.
Synthesis and Spectroscopic Characterization
o-Aminophenylbenzimidazole was prepared by adopting a literature method [23] . A mixture of o-aminophenylbenzimidazole (0.05 mol, 10.45 g) and p-dimethylamino benzaldehyde (0.05 mol, 6.66 g) in 200 ml of ethanol was refluxed for 5 h. The resulting solution was evaporated under reduced pressure to a small volume to obtain a yellow compound. It was separated and recrystallized from ethanol to get 6-p-dimethylaminophenyl-5,6-dihydrobenzoimidazo[1,2-c] quinazoline (I) as a cream crystalline solid. Compounds II through V were prepared as reported earlier [24] [25] [26] [27] .
Elemental analysis for 6-p-dimethylaminophenyl-5,6-dihydrobenzoimidazo [1,2-c] 
X-ray Crystallography
Suitable single crystals of I for X-ray diffraction study were grown by slow evaporation from concentrated ethanol solution. Measurements were made using graphite monochromated CuKa radiation (k = 1.54180 Å ) on an EnrafNonius CAD-4 diffractometer using x-2h scan mode. The crystals of compound I belong to the monoclinic space group P2 1 /n with unit cell parameters a = 10.652(2) Å , b = 11.002(2) Å , c = 15.753(2) Å , b = 109.00(2)°. The intensities were corrected for Lorentz, polarization and absorption. The crystal structure was solved by direct methods and refined by full-matrix least squares method using SHELX97 [28] . The non-hydrogen atoms were refined anisotropically and the hydrogen atoms were refined isotropically. The refinement was continued until the maximum shift/e.s.d was zero. Crystal data, intensity collection conditions and refinement parameters are presented in Table 1 .
Antimicrobial Activity
The antimicrobial activity of the N-heterocycles, I, II and III against the bacterial strain Bacillus subtilis and the fungus Yeast was investigated. The test solutions (50 ppm concentration) were prepared in DMSO for evaluating the biological activity. Cup-plate method was employed and the tests were carried out at room temperature. The experimental plates were incubated for 24 h and the zone of inhibition was measured. The drug action was estimated on the basis of percentage growth inhibition of the cultures. Goodness-of-fit on F Percentage inhibition was calculated with standard antibiotic Septran and standard antifungal agent Grissoflumin as reference.
Results and Discussion
o-Aminophenylbenzimidazole reacts with p-dimethylamino benzaldehyde in ethanol to produce 6-p-dimethylaminophenyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline (I). The reaction may occur in two steps, the first one being the nucleophilic attack of amine, o-aminophenylbenzimidazole on the aldehyde, p-dimethylamino benzaldehyde leading to the formation of carbinolamine by coupling. In the second step, the carbinolamine undergoes cyclisation followed by the loss of a molecule of water to produce the product (I) as illustrated in Scheme . The assignments of the other bands along with the spectral data which have not been reported earlier of the related quinazoline derivatives, II-V are listed in Table 2 [30] . The UV-Vis spectrum of I exhibited absorption bands assignable to p ! pÃ transitions and these are listed in Table 3 along with the spectral data of related quinazoline derivatives.
The mass spectrum of I showed a parent ion peak at m/z 340. The compound undergoes fragmentation and the resultant pattern along with m/z values are depicted in Scheme 2.
The 1 H NMR spectrum of o-aminophenylbenzimidazole exhibited resonance peaks due to NH 2 of the amino group and NH of benzimidazole at 6.97 and 6.75 d respectively. When this heterocycle was reacted with p-dimethylamino benzaldehyde the NH resonance peak was observed at 7.4 d and the NH 2 resonance disappeared in the spectrum. The aldehydic proton resonance of p-dimethylamino benzaldehyde, observed at 9.66 d, after condensation has undergone upfield shift and it was observed at 6.86 d. Product R Name (R) 
X-ray Crystallography of Compound I
The X-ray crystallographic study on I has shown that the fused benzimidazole ring is roughly planar with a maximum deviation of 0.015(3) Å for atom C9 (Fig. 1) . The geometrical parameters of the imidazole ring system are consistent with those reported in the literature [31] . The bond lengths and angles within the central dihydropyrim- [32] . The quinazoline ring has deviated from planarity with deviation of 0.272(3) Å at C17 from the least squares plane defined by atoms N1/C9/ C10/C15/N16/C17. The imidazole and dihydropyrimidine rings are nearly co-planar as indicated by the dihedral angle of 5.05(2)°. The dihedral angle of 84.85(2)°between the planes of dimethylaminophenyl and the dihydropyrimidine rings indicates that the latter is nearly orthogonal to the former. A study of the torsion angles, asymmetric parameters and least squares plane calculations reveal that the dihydropyrimidine ring is in the skew-boat conformation, which is confirmed by the puckering parameters [33] , Q = 0.402 Å , h = 60.1°and / = 286.99°. Similar skew boat conformations were reported in 5,6-dihydroimidazo[1,2-c]quinazolines [26, 34, 35] . There are several reported structures where the dihydropyrimidine ring existed in half chair/flat boat type conformation [36] [37] [38] [39] [40] [41] [42] [43] . The torsion angles of 63.0(3)°and -55.5(4)°for N16-C17-C18-C23 and N1-C17-C18-C23 respectively determine the inter-ring conformation of the junction between dimethylaminophenyl ring and the dihydrobenzimidazoquinazoline ring. This value being close to 60°indicates that the dimethylaminophenyl ring bisects the plane of the dihydrobenzimidazo quinazoline ring. The molecule possesses a chiral center at C17. The dimethylamino group is essentially planar (sum of the bond angles at N24 is 358°) and nearly coplanar with the adjacent phenyl ring C18/C19/C20/C21/C22/C23 (dihedral angles 170.6(3)°and 11.1(4)°). The atoms N24, C25 and C26 of the dimethylamino group have deviations of 0.051(3) Å , -0.059(3) Å and -0.150(3) Å respectively from the least squares plane of the phenyl ring C18/C19/C20/C21/C22/C23. The planarity of the dimethylamino group may increase the conjugation with the phenyl ring. The dimethylamino group is clearly conjugated with phenyl ring as indicated by the N24-C21 bond length [1.377(4) Å ] and the bond angles around N24. The packing of molecules down a-axis is shown in Fig. 2 . The structure exhibits intermolecular hydrogen bonds of the type C-H-N. The intermolecular hydrogen bonds are between the nitrogen of the imidazole ring of one molecule and the 
The bond lengths in the 6-phenyl group of I have changed compared with other derivatives due to the para substitution of the dimethylamino group (Table 4) . While the bond lengths C22-C23, C21-C22 and C20-C21 (Fig. 3) are elongated, the bond lengths C19-C20, C18-C19 and C18-C23 are shortened (Table 4) Table 5 . The antimicrobial activity of I, II and III against the bacterial strain Bacillus subtilis and the fungus Yeast reveal that I and II are slightly more toxic as compared to the standard with respect to Yeast but showed no toxicity against Bacillus subtilis ( Table 6 ). The substituents in para positions (dimethyl amino group in I and hydroxyl group in II) are electron donating and do not show any bacterial growth inhibition. These substituents show appreciable growth inhibition as compared to the standards in the case of the fungus Yeast. The substituent in III (phenyl) which has hydrogen in the para position shows moderate antimicrobial activity for both the microbes as compared to I and II.
Conclusion
In conclusion, the reaction of o-aminophenyl benzimidazole with substituted aldehydes has resulted in the formation of quinazoline derivatives via cyclisation with the elimination of water molecule(s). 1 H and 13 C NMR spectral data have supported the formation of cyclised products. X-ray crystallographic studies have confirmed the cyclisation and have revealed the influence of the substituent R on the dihydropryrimidine ring with respect to bond lengths and bond angles. The dihydropyrimidine ring is in a skew-boat conformation in I and the dimethylamino group is clearly conjugated with the phenyl ring which it is attached to. Antimicrobial activity of I, II and III against the bacterial strain Bacillus subtilis and the fungus Yeast reveal that I and II are slightly more toxic as compared to the standard with respect to Yeast but showed no toxicity against Bacillus subtilis.
Supplementary Material
Crystallographic data for the structural analysis of compound I have been deposited with the Cambridge Crystallographic Data Centre (CCDC) as 742983. Copies of the data can be obtained free of charge via http://www.ccdc. cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge, CB2 1EZ, U.K.; Fax: ?44 1223 336033; e-mail: deposit@ ccdc.cam.ac.uk). 
